Yoshihiro Takahashi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Glycemic Control

Top Venues

Journal of diabetes investigation

BMC endocrine disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshihiro Takahashi, Masanori Murayama, Kaoru Noda, Kengo Yamakawa, Yuya Koide, Rie Yamada, Makoto Hayashi, Keigo Yasuda
Cefcapene pivoxil-induced hypocarnitinemic hypoglycemia in elderly man with subclinical ACTH deficiency: a case report. BMC endocrine disorders 23 (1) (2023)
Shohei Nishida, Takehiro Kato, Yuichi Hayashi, Shoya Yamada, Hironori Fujii, Michi Yamada, Nao Asai, Shinya Shimizu, Takashi Niwa, Hirotoshi Iihara, Sodai Kubota, Mayu Sakai, Yoshihiro Takahashi, Ken Takao, Masami Mizuno, Takuo Hirota, Ryo Kobayashi, Yukio Horikawa, Daisuke Yabe, Akio Suzuki
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus. Journal of diabetes investigation (2023)
Yoshihiro Takahashi, Masanori Murayama, Kaoru Noda, Kengo Yamakawa, Yuya Koide, Rie Yamada, Makoto Hayashi, Keigo Yasuda
Cefcapene pivoxil-induced hypocarnitinemic hypoglycemia in elderly man with subclinical ACTH deficiency: a case report. BMC endocrine disorders 23 (1) (2023)
Yoshihiro Takahashi, Yutaka Seino, Daisuke Yabe
Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes. Journal of diabetes investigation (2023)
Yoshihiro Takahashi, Masanori Murayama, Kaoru Noda, Kengo Yamakawa, Yuya Koide, Rie Yamada, Makoto Hayashi, Keigo Yasuda
Cefcapene pivoxil-induced hypocarnitinemic hypoglycemia in elderly man with subclinical ACTH deficiency: a case report. BMC endocrine disorders 23 (1) (2023)
Sodai Kubota, Takuya Haraguchi, Hitoshi Kuwata, Yusuke Seino, Kenta Murotani, Takumi Tajima, Gen Terashima, Makiko Kaneko, Yoshihiro Takahashi, Ken Takao, Takehiro Kato, Kenichiro Shide, Saeko Imai, Atsushi Suzuki, Yasuo Terauchi, Yuichiro Yamada, Yutaka Seino, Daisuke Yabe
Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan. Journal of diabetes investigation (2022)